| 000 | 01427 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516185702.0 | ||
| 264 | 0 | _c20140811 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdt512 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTafuri, G | |
| 245 | 0 | 0 |
_aHow do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers' views. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJan 2014 |
||
| 300 |
_a265-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDecision Making |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aStolk, P | |
| 700 | 1 | _aTrotta, F | |
| 700 | 1 | _aPutzeist, M | |
| 700 | 1 | _aLeufkens, H G | |
| 700 | 1 | _aLaing, R O | |
| 700 | 1 | _aDe Allegri, M | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 25 _gno. 1 _gp. 265-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdt512 _zAvailable from publisher's website |
| 999 |
_c23384776 _d23384776 |
||